TWI623492B - Method for preparing tetracalcium phosphate - Google Patents

Method for preparing tetracalcium phosphate Download PDF

Info

Publication number
TWI623492B
TWI623492B TW106103267A TW106103267A TWI623492B TW I623492 B TWI623492 B TW I623492B TW 106103267 A TW106103267 A TW 106103267A TW 106103267 A TW106103267 A TW 106103267A TW I623492 B TWI623492 B TW I623492B
Authority
TW
Taiwan
Prior art keywords
powder
tetracalcium phosphate
fish scale
calcium
phosphate
Prior art date
Application number
TW106103267A
Other languages
Chinese (zh)
Other versions
TW201827339A (en
Inventor
江世哲
廖三棨
鄭瑞濱
Original Assignee
潤泰精密材料股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 潤泰精密材料股份有限公司 filed Critical 潤泰精密材料股份有限公司
Priority to TW106103267A priority Critical patent/TWI623492B/en
Priority to CN201710242621.4A priority patent/CN108358183A/en
Priority to JP2017088312A priority patent/JP6318282B1/en
Application granted granted Critical
Publication of TWI623492B publication Critical patent/TWI623492B/en
Publication of TW201827339A publication Critical patent/TW201827339A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B25/00Phosphorus; Compounds thereof
    • C01B25/16Oxyacids of phosphorus; Salts thereof
    • C01B25/26Phosphates
    • C01B25/32Phosphates of magnesium, calcium, strontium, or barium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/12Phosphorus-containing materials, e.g. apatite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/02Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2002/00Crystal-structural characteristics
    • C01P2002/70Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
    • C01P2002/72Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by d-values or two theta-values, e.g. as X-ray diagram
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00Particle morphology
    • C01P2004/60Particles characterised by their size
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00Particle morphology
    • C01P2004/60Particles characterised by their size
    • C01P2004/61Micrometer sized, i.e. from 1-100 micrometer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

本發明提供一種製備磷酸四鈣的方法,其包含:(1)熱處理一魚鱗,並將該魚鱗研磨成粉體,得一魚鱗粉體;(2)添加一原料於該魚鱗粉體中,改變該魚鱗粉體中的礦物成分,得一生料粉體;以及(3)高溫燒結該生料粉體,得一含有一磷酸四鈣之混合物。 The invention provides a method for preparing tetracalcium phosphate, which comprises: (1) heat-treating a fish scale and grinding the fish scale into a powder to obtain a fish scale powder; (2) adding a raw material to the fish scale powder to change The mineral components in the fish scale powder are used to obtain a raw meal powder; and (3) the raw meal powder is sintered at a high temperature to obtain a mixture containing tetracalcium phosphate.

Description

製備磷酸四鈣的方法 Method for preparing tetracalcium phosphate

本發明係關於一種製備磷酸四鈣的方法,其特徵在於,使用魚鱗為原料轉化成磷酸四鈣。 The invention relates to a method for preparing tetracalcium phosphate, which is characterized in that fish scale is used as a raw material to transform into tetracalcium phosphate.

人體組織修復材料研究和開發是全球關注的議題,磷酸鈣骨水泥(Calcium Phosphate Cement;CPC)是一種具有自固性能非陶瓷氫氧基磷灰石類人工骨材料。由固相粉末和固化液依一定比例混合製成,其中固相粉末由一種或多種磷酸鈣鹽所組成,而固化液則由水、磷酸鹽溶液、稀磷酸、生理食鹽水、與血液等共同組成。固相粉末與固化液混合後形成易塑形漿體,於短時間及適當溫度(室溫或接近人體溫度)下自行固化,形成與骨組織的無機成分和晶相結構相似的磷灰石,具有良好的生物相容性、骨傳導性、可降解性、可塑性,在人體生理環境下自行固化,且固化反應不產熱等優點,在骨植入與修復領域被廣泛應用。目前磷酸鈣水泥的製程,無法達到大量生產。目前發表的磷酸鈣水泥相關的文獻中,實驗材料的來源,大多停留在實驗室自行配製的階段。以常用的磷酸四鈣加二水磷酸氫鈣(TTCP+DCPD)系列為例:二水磷酸氫鈣(dicalcium phosphate dehydrate;DCPD)粉末是以試藥級的硝酸鈣(Ca(NO3)2)溶液與磷酸氫二 銨((NH4)2HPO4)溶液於酸性條件下通過液相沈澱而生成;而磷酸四鈣(tetracalcium phosphate;TTCP)粉末則是將二水磷酸氫鈣(DCPD)與碳酸鈣(CaCO3)於1550℃下燒結約10小時製得。是故改良生產方法以提高產能,為此一材料商業化的重要關鍵。 The research and development of human tissue repair materials is a topic of global concern. Calcium Phosphate Cement (CPC) is a non-ceramic hydroxyapatite artificial bone material with self-setting properties. It is made by mixing solid phase powder and solidified liquid in a certain ratio, where solid phase powder is composed of one or more calcium phosphate salts, and solidified liquid is composed of water, phosphate solution, dilute phosphoric acid, physiological saline, and blood. composition. The solid-phase powder is mixed with the solidifying liquid to form an easy-to-shape slurry, which is cured on its own in a short time and at an appropriate temperature (room temperature or close to the temperature of the human body) to form apatite similar to the inorganic components and crystal structure of the bone tissue. It has good biocompatibility, osteoconductivity, degradability, plasticity, self-curing under the physiological environment of the human body, and the curing reaction does not produce heat. It is widely used in the field of bone implantation and repair. The current process of calcium phosphate cement cannot achieve mass production. In the currently published literature on calcium phosphate cement, the source of experimental materials mostly stays in the laboratory's own preparation stage. Taking the commonly used series of tetracalcium phosphate and dibasic calcium phosphate (TTCP + DCPD) as an example: dicalcium phosphate dehydrate (DCPD) powder is based on reagent grade calcium nitrate (Ca (NO 3 ) 2 ) The solution and diammonium hydrogen phosphate ((NH 4 ) 2 HPO 4 ) solution are formed by liquid-phase precipitation under acidic conditions; and tetracalcium phosphate (TTCP) powder is obtained by combining DCPD with DCPD and Calcium carbonate (CaCO 3 ) was prepared by sintering at 1550 ° C for about 10 hours. Therefore, it is important to improve the production method to increase the production capacity.

魚鱗是魚類的皮膚的衍生物,具有保護魚類身體的功能,防止微生物侵入機體,抵抗疾病和避免感染。而依據鱗片的構造特點,魚鱗可分為骨鱗(bony scale)、硬鱗(ganoid scale)及盾鱗(placoid scale),其中骨鱗又可分為圓鱗(cycloid scale)和櫛鱗(ctenoid scale),骨鱗為硬骨魚類最常見的魚鱗。魚鱗的主要成分中含有45%的膠原蛋白(collagen)和55%的氫氧基磷灰石(hydroxyapatite;HAp),其中氫氧基磷灰石是一種磷酸鈣化合物,也是人體或動物骨骼及牙齒的主要無機成分,在骨骼中約占60~70%。由於氫氧基磷灰石中之晶粒特性及該等晶粒間形成之微小孔隙,能使氫氧基磷灰石對骨骼有良好的生物親和力,對牙齒有再石灰化的功能,此外,尚因其具有良好的生物活性,故,在臨床上,已被廣泛地應用在骨科及牙科用的生醫材料上,如:人工骨頭、人工牙齒、硬骨補綴、人工關節等。 Fish scales are derivatives of the skin of fish, which have the function of protecting the fish body, preventing microorganisms from invading the body, resisting diseases and avoiding infection. According to the structural characteristics of scales, fish scales can be divided into bone scales, ganoid scales and placoid scales. Among them, bone scales can be divided into cycloid scales and ctenoid scales. scale), the bone scale is the most common fish scale of teleost fish. The main ingredients of fish scales contain 45% collagen and 55% hydroxyapatite (HAp). Among them, hydroxyapatite is a calcium phosphate compound, which is also human or animal bones and teeth. The main inorganic component of sulphonate is about 60 ~ 70% in bones. Due to the grain characteristics of the hydroxyl apatite and the tiny pores formed between these grains, the hydroxyl apatite can have a good biological affinity for bones and a function of recalcification of teeth. In addition, Because of its good biological activity, it has been widely used in clinical orthopedic and dental biomedical materials, such as artificial bones, artificial teeth, hard bone repair, artificial joints, etc.

美國專利公開第2009/0036656號及第2005/0191226號,和美國專利公告第7838038號指出,利用魚鱗作為原料使用,透過機械研磨與篩分方式,或是以高溫700℃熱前處理後再以1500℃燒結後,可製備生物醫學用人體組織修復材料,然而,此類型磷酸鹽系組織修復材料製備方式仍存在製備效率低、高溫熱處理、與純度低等缺點。 U.S. Patent Publication Nos. 2009/0036656 and 2005/0191226 and U.S. Patent Publication No. 7838038 point out that fish scales are used as raw materials, either through mechanical grinding and sieving, or after high temperature 700 ° C thermal pretreatment before After sintering at 1500 ° C, biomedical tissue repair materials can be prepared. However, this type of phosphate-based tissue repair materials still has disadvantages such as low preparation efficiency, high temperature heat treatment, and low purity.

是以,將魚鱗用於製備生物材料的製備上,若能改良製程,如簡化製備步驟或提高純度等,將更有助提高魚鱗之附加價值。 Therefore, if fish scales are used for the preparation of biological materials, if the manufacturing process can be improved, such as simplifying the preparation steps or increasing the purity, the added value of fish scales will be further enhanced.

本發明係利用魚鱗以製備高純度磷酸四鈣粉體;魚鱗經380℃熱處理後會破壞魚鱗的有機質,再去破碎研磨成粉體,該粉體對30號篩網(ASTM No.30 mesh)之過篩率可達100%;之後利用重量百分比0%、10%、15%、20%、與25%添加比例之碳酸鈣與該粉體進行混合得一混合物,該混合物利用1350℃燒結6小時並進行快速冷卻處理後,可得含有一磷酸四鈣之混合物。而該含有一磷酸四鈣之混合物之X-光繞射(X-ray diffraction;XRD)試驗結果顯示,未添加碳酸鈣之魚鱗經高溫燒結仍為氫氧機磷灰石結構(hydroxyapatite;HAp),而隨著碳酸鈣添加比例增加,磷酸四鈣礦物相生成越多,然而當添加比例大於25%時,磷酸四鈣粉體存在多餘的游離石灰(f-CaO),無法充分反應;該混合物內氧化鈣對五氧化二磷(CaO/P2O5)比例較佳為1.45,以CaO/P2O5為1.45所得之磷酸四鈣純度大於90%。因此利用魚鱗以一定溫度進行魚鱗熱處理,再搭配氧化鈣前驅物(石灰石或牡蠣殼等),以類似波特蘭水泥(portland cement)製程技術,透過生料研磨、高溫燒結以及快速激冷之製程,可製備90%以上高純度之磷酸四鈣,且符合醫療級磷酸四鈣規格中的重金屬含量標準;故本發明的方法是一種簡單快速的磷酸四鈣製備技術方法。 The present invention uses fish scales to prepare high-purity tetracalcium phosphate powder; after heat treatment at 380 ° C, the fish scales will destroy the organic matter of the fish scales, and then they will be crushed and ground into a powder. The powder is used for a No. 30 mesh The sieving rate can reach 100%; after that, calcium carbonate and 0%, 10%, 15%, 20%, and 25% added proportions are mixed with the powder to obtain a mixture, and the mixture is sintered at 1350 ° C. 6 After hours and rapid cooling, a mixture containing tetracalcium monophosphate can be obtained. The X-ray diffraction (XRD) test results of the mixture containing tetracalcium phosphate monophosphate showed that the fish scales without calcium carbonate were still hydroxyapatite (HAp) after high temperature sintering. With the increase of the calcium carbonate addition ratio, the more tetracalcium phosphate mineral phase is generated, however, when the addition ratio is greater than 25%, there is excess free lime (f-CaO) in the tetracalcium phosphate powder, which cannot fully react; the mixture The ratio of internal calcium oxide to phosphorus pentoxide (CaO / P 2 O 5 ) is preferably 1.45, and the purity of tetracalcium phosphate obtained with CaO / P 2 O 5 as 1.45 is greater than 90%. Therefore, the fish scale is heat-treated at a certain temperature by using fish scales, and then matched with calcium oxide precursors (limestone or oyster shells, etc.), using a process similar to portland cement, through raw material grinding, high temperature sintering and rapid chilling. It can prepare more than 90% high-purity tetracalcium phosphate and meet the heavy metal content standard in medical grade tetracalcium phosphate specifications; therefore, the method of the present invention is a simple and rapid method for preparing tetracalcium phosphate.

本文中的用語「一」或「一種」係用以敘述本發明之元件及成分。此術語僅為了敘述方便及給予本發明之基本觀念。此敘述應被理解 為包括一種或至少一種,且除非明顯地另有所指,表示單數時亦包括複數。於申請專利範圍中和”包含”一詞一起使用時,該用語「一」可意謂一個或超過一個。 The terms "a" or "an" are used herein to describe the elements and ingredients of the invention. This term is used merely for convenience of description and to give the basic idea of the present invention. This narrative should be understood To include one or at least one, and unless explicitly indicated otherwise, the singular also includes the plural. When used with the term "comprising" in the scope of a patent application, the term "a" may mean one or more than one.

本文中的用語「或」其意同「及/或」。 The term "or" in this text means "and / or".

本發明提供一種製備磷酸四鈣的方法,其包含:(1)熱處理一魚鱗,並將該魚鱗研磨成粉體,得一魚鱗粉體;(2)添加一原料於該魚鱗粉體中,得一生料粉體,其中該原料係選自一氧化鈣、一氧化鈣前驅物、一五氧化二磷及一五氧化二磷前驅物所組成的群組;以及(3)高溫燒結該生料粉體,使該生料粉體中的氧化鈣對五氧化二磷(CaO/P2O5)之莫耳比值的範圍為1.2至1.7,且高溫燒結完成後得一含有一磷酸四鈣(tetracalcium phosphate;TTCP)之混合物。 The invention provides a method for preparing tetracalcium phosphate, which comprises: (1) heat-treating a fish scale and grinding the fish scale into a powder to obtain a fish scale powder; (2) adding a raw material to the fish scale powder to obtain A raw meal powder, wherein the raw material is selected from the group consisting of calcium monoxide, a precursor of calcium monoxide, a phosphorus pentaoxide and a phosphorus pentaoxide precursor; and (3) sintering the raw meal powder at high temperature The molar ratio of calcium oxide to phosphorus pentoxide (CaO / P 2 O 5 ) in the raw meal powder is in the range of 1.2 to 1.7, and a tetracalcium monotetraphosphate (tetracalcium) is obtained after high temperature sintering is completed. phosphate; TTCP).

於一具體實施例中,該魚鱗之種類包含骨鱗(bony scale)、硬鱗(ganoid scale)及盾鱗(placoid scale)。於一具體實施例中,該魚鱗包含一氫氧機磷灰石(hydroxyapatite;HAp)、一氧化鈣(CaO)以及五氧化二磷(CaO/P2O5)。 In a specific embodiment, the types of fish scales include a bone scale, a ganoid scale, and a placoid scale. In a specific embodiment, the fish scale includes a hydroxyapatite (HAp), calcium monoxide (CaO), and phosphorus pentoxide (CaO / P 2 O 5 ).

為了使魚鱗之後能與原料粉末(如碳酸鈣)進行均勻混合以製備出磷酸四鈣,因此魚鱗必須經過破碎研磨處理成粉末狀。然因魚鱗為有機質膠原蛋白與無機質氫氧基磷酸石所組合而成,故具有一定的韌性特質;故本發明將魚鱗經熱處理(如大於380℃)後,可有效破壞魚鱗內部有機質結構,使魚鱗能夠高效率處理研磨成粉末狀態。於一具體實施例中,該熱處理之溫度大於300℃。於一較佳具體實施例中,該熱處理之溫度大於 350℃。於一更佳具體實施例中,該熱處理之溫度大於380℃。於另一具體實施例中,該熱處理之時間大於30分鐘。於一較佳具體實施例中,該熱處理之時間大於1小時。於一更佳具體實施例中,該熱處理之時間大於2小時。 In order to make the fish scales uniformly mixed with the raw material powder (such as calcium carbonate) to prepare tetracalcium phosphate, the fish scales must be crushed and ground into powder. However, because the fish scale is a combination of organic collagen and inorganic hydroxide phosphate stone, it has certain toughness characteristics; therefore, the fish scale can effectively destroy the internal organic structure of the fish scale after heat treatment (for example, greater than 380 ° C), so that Fish scales can be efficiently ground and ground. In a specific embodiment, the temperature of the heat treatment is greater than 300 ° C. In a preferred embodiment, the temperature of the heat treatment is greater than 350 ° C. In a more specific embodiment, the temperature of the heat treatment is greater than 380 ° C. In another embodiment, the heat treatment time is greater than 30 minutes. In a preferred embodiment, the heat treatment time is greater than 1 hour. In a more specific embodiment, the heat treatment time is greater than 2 hours.

本文中的”研磨”可採用習知的研磨方式,而不需加以限制,較佳為球磨。於一具體實施例中,該魚鱗粉體之粒徑範圍為20μm至800μm。於一較佳具體實施例中,該魚鱗粉體之粒徑範圍為50μm至700μm。於一更佳具體實施例中,該魚鱗粉體之粒徑範圍為75μm至600μm。 The "grinding" herein may be a conventional grinding method without limitation, and ball milling is preferred. In a specific embodiment, the particle size of the fish scale powder ranges from 20 μm to 800 μm. In a preferred embodiment, the particle size of the fish scale powder ranges from 50 μm to 700 μm. In a more specific embodiment, the particle size of the fish scale powder ranges from 75 μm to 600 μm.

為了使生料粉體於高溫燒結的過程中,該生料粉體中的氧化鈣對五氧化二磷(CaO/P2O5)之莫耳比值要到一特定範圍,以燒結出磷酸四鈣之礦物。因此,要視魚鱗粉體本身之原有的氧化鈣以及五氧化二磷的重量百分比,以決定該原料的添加種類以及添加量,例如單獨添加該氧化鈣前驅物(或氧化鈣)或該五氧化二磷前驅物(或五氧化二磷),或是同時該氧化鈣前驅物(或氧化鈣)及該五氧化二磷前驅物(或五氧化二磷),以讓該原料與該魚鱗粉體混合所得的該生料粉體於燒結過程中,其氧化鈣對五氧化二磷(CaO/P2O5)之莫耳比值達到特定範圍。於一具體實施例中,該原料之形狀為一粉末狀。於一較佳具體實施例中,該原料為一原料粉末。 In order to make the raw meal powder sintered at high temperature, the molar ratio of calcium oxide to phosphorus pentoxide (CaO / P 2 O 5 ) in the raw meal powder should be in a specific range to sinter the tetraphosphoric acid powder. Minerals of calcium. Therefore, depending on the weight percentage of the original calcium oxide and phosphorus pentoxide of the fish scale powder itself, in order to determine the type and amount of the raw material, for example, the calcium oxide precursor (or calcium oxide) or the five Phosphorus oxide precursor (or phosphorus pentoxide), or both the calcium oxide precursor (or calcium oxide) and the phosphorus pentoxide precursor (or phosphorus pentoxide), so that the raw material and the fish scale meal During the sintering process of the raw meal powder obtained by the bulk mixing, the molar ratio of calcium oxide to phosphorus pentoxide (CaO / P 2 O 5 ) reaches a specific range. In a specific embodiment, the shape of the raw material is a powder. In a preferred embodiment, the raw material is a raw material powder.

因此,本發明的目的在於使生料粉體於高溫燒結的過程中,該生料粉體中的氧化鈣對五氧化二磷(CaO/P2O5)之莫耳比值要到一特定範圍。故本發明可採取下列兩種方式:(1)於該魚鱗粉體直接添加氧化鈣或五氧化二磷,或者是氧化鈣和五氧化二磷兩者都添加,以讓該生料粉體 中氧化鈣對五氧化二磷(CaO/P2O5)之莫耳比值於燒結前就達到特定範圍;或(2)於該魚鱗粉體添加氧化鈣前驅物(如碳酸鈣)或五氧化二磷前驅物,或者是氧化鈣前驅物和五氧化二磷前驅物兩者都添加;因此於燒結過程中,氧化鈣前驅物能經加熱反應而產生氧化鈣以及五氧化二磷前驅物經加熱反應而產生五氧化二磷,一樣可使該生料粉體中氧化鈣和五氧化二磷的成份比例發生變化,讓其氧化鈣對五氧化二磷(CaO/P2O5)之莫耳比值於燒結過程中同樣能達到特定範圍。 Therefore, the purpose of the present invention is to make the raw meal powder sintered at a high temperature, and the molar ratio of calcium oxide to phosphorus pentoxide (CaO / P 2 O 5 ) in the raw meal powder should be in a specific range. . Therefore, the present invention can adopt the following two methods: (1) directly adding calcium oxide or phosphorus pentoxide to the fish scale powder, or both calcium oxide and phosphorus pentoxide, so that the raw meal powder The molar ratio of calcium oxide to phosphorus pentoxide (CaO / P 2 O 5 ) reaches a specific range before sintering; or (2) adding calcium oxide precursors (such as calcium carbonate) or dipentoxide to the fish scale powder Phosphorus precursors, or both calcium oxide precursors and phosphorus pentoxide precursors are added; therefore, during the sintering process, the calcium oxide precursors can be heated to produce calcium oxide and the phosphorus pentoxide precursors can be heated. The production of phosphorus pentoxide can also change the proportion of calcium oxide and phosphorus pentoxide in the raw meal powder, so that the molar ratio of calcium oxide to phosphorus pentoxide (CaO / P 2 O 5 ) It can also reach a specific range during the sintering process.

本文中「氧化鈣前驅物」一詞包含但不限於一能經反應產生氧化鈣之物質。於一具體實施例中,該氧化鈣前驅物包含一碳酸鈣、一葡萄酸鈣及一檸檬酸鈣。於一較佳具體實施例中,該氧化鈣前驅物包含一碳酸鈣。 The term "calcium oxide precursor" as used herein includes, but is not limited to, a substance that can react to produce calcium oxide. In a specific embodiment, the calcium oxide precursor includes calcium carbonate, calcium gluconate, and calcium citrate. In a preferred embodiment, the calcium oxide precursor comprises calcium carbonate.

本文中「五氧化二磷前驅物」一詞包含但不限於一能經反應產生五氧化二磷之物質。於一具體實施例中,該五氧化二磷前驅物包含一磷灰石、一氫氧基磷灰石、一二水磷酸氫鈣及一魚鱗。 The term "phosphorus pentoxide precursor" as used herein includes, but is not limited to, a substance capable of producing phosphorus pentoxide through reaction. In a specific embodiment, the phosphorous pentoxide precursor includes an apatite, a monohydroxyapatite, calcium hydrogen phosphate dihydrate, and a fish scale.

由於要於高溫燒結時,該生料粉體中的氧化鈣對五氧化二磷(CaO/P2O5)之莫耳比值要到一特定範圍方能產生出磷酸四鈣之礦物。於一較佳具體實施例中,該生料粉體中的氧化鈣對五氧化二磷(CaO/P2O5)之莫耳比值的範圍為1.35至1.67。於一更佳具體實施例中,該生料粉體中的氧化鈣對五氧化二磷(CaO/P2O5)之莫耳比值的範圍為1.4至1.6。 When sintering at high temperature, the molar ratio of calcium oxide to phosphorus pentoxide (CaO / P 2 O 5 ) in the raw meal powder must be within a specific range to produce a mineral of tetracalcium phosphate. In a preferred embodiment, the molar ratio of calcium oxide to phosphorus pentoxide (CaO / P 2 O 5 ) in the raw meal powder ranges from 1.35 to 1.67. In a more specific embodiment, the molar ratio of calcium oxide to phosphorus pentoxide (CaO / P 2 O 5 ) in the raw meal powder ranges from 1.4 to 1.6.

本發明的生料粉體須經高溫燒結,以使該生料粉體中的氧化鈣(CaO)與氫氧基磷灰石(HAp)發生鍵結反應,逐漸生長出磷酸四鈣之 礦物相。本文中的「高溫燒結」一詞包含利用高溫爐進行燒結,其中該高溫爐包含一電窯、一瓦斯窯以及一材窯。於一具體實施例中,該高溫燒結之溫度大於1000℃。於一較佳具體實施例中,該高溫燒結之溫度大於1200℃。於一更佳具體實施例中,該高溫燒結之溫度大於1350℃。於另一具體實施例中,該高溫燒結之時間大於0.5小時。於一較佳具體實施例中,該高溫燒結之時間大於2小時。於一更佳具體實施例中,該高溫燒結之時間大於6小時。 The raw meal powder of the present invention must be sintered at high temperature so that the calcium oxide (CaO) in the raw meal powder reacts with the hydroxide apatite (HAp) to gradually grow the tetracalcium phosphate. Mineral phase. The term "high temperature sintering" herein includes sintering using a high temperature furnace, which includes an electric kiln, a gas kiln, and a material kiln. In a specific embodiment, the temperature of the high-temperature sintering is greater than 1000 ° C. In a preferred embodiment, the high-temperature sintering temperature is greater than 1200 ° C. In a more specific embodiment, the high-temperature sintering temperature is greater than 1350 ° C. In another embodiment, the high-temperature sintering time is greater than 0.5 hours. In a preferred embodiment, the high-temperature sintering time is greater than 2 hours. In a more specific embodiment, the high-temperature sintering time is greater than 6 hours.

此外,為保有生料粉體於高溫燒結完成時的礦物相活性,即維持該含有該磷酸四鈣之混合物中的該磷酸四鈣含量。因此,本發明進一步包含一步驟(4),其接於步驟(3)後,其包含冷卻該含有該磷酸四鈣之混合物。本文中的「冷卻」包含但不限於快速冷卻,即燒結完成後立刻進行冷卻的動作。於一具體實施例中,該冷卻係以利用溫差方式進行冷卻。於另一具體實施例中,該溫差方式為該冷卻之溫度低於該高溫燒結之溫度800℃以上。於一較佳具體實施例中,該溫差方式為該冷卻之溫度低於該高溫燒結之溫度1000℃以上。於一更佳具體實施例中,該溫差方式為該冷卻之溫度低於該高溫燒結之溫度1200℃以上。因此,將高溫燒結(如1350℃以上)後所產生的該含有該磷酸四鈣之混合物直接於室溫下(約25℃)冷卻,瞬間溫差差異極大,就可達到快速冷卻的效果。於一具體實施例中,該冷卻該含有該磷酸四鈣之混合物係將該含有該磷酸四鈣之混合物於室溫冷卻。此「冷卻」步驟的目的在於維持剛燒結完的該含有該磷酸四鈣之混合物的礦物成分,因若是將剛燒結完的該含有該磷酸四鈣之混合物仍置於高 溫爐內慣優降溫,則有可能導致該含有該磷酸四鈣之混合物中的礦物成分的變化,即該磷酸四鈣的含量會降低;因此,透過快速冷卻的步驟,可保有剛燒結完的該含有該磷酸四鈣之混合物之礦物成分,得到含有較高純度的磷酸四鈣之產物。 In addition, in order to maintain the mineral phase activity of the raw powder when the high temperature sintering is completed, the tetracalcium phosphate content in the mixture containing the tetracalcium phosphate is maintained. Therefore, the present invention further includes a step (4), which is subsequent to the step (3), and comprises cooling the mixture containing the tetracalcium phosphate. "Cooling" in this article includes but is not limited to rapid cooling, that is, cooling is performed immediately after sintering is completed. In a specific embodiment, the cooling is performed by using a temperature difference method. In another embodiment, the temperature difference mode is that the cooling temperature is lower than the high temperature sintering temperature by 800 ° C or more. In a preferred embodiment, the temperature difference mode is that the cooling temperature is lower than the high-temperature sintering temperature by more than 1000 ° C. In a more specific embodiment, the temperature difference mode is that the cooling temperature is lower than the high temperature sintering temperature by more than 1200 ° C. Therefore, the mixture containing the tetracalcium phosphate produced after high-temperature sintering (eg, above 1350 ° C) is directly cooled at room temperature (about 25 ° C), and the instantaneous temperature difference is extremely large, and the effect of rapid cooling can be achieved. In a specific embodiment, the cooling the mixture containing the tetracalcium phosphate is cooling the mixture containing the tetracalcium phosphate at room temperature. The purpose of this "cooling" step is to maintain the mineral composition of the mixture containing the tetracalcium phosphate just after sintering. The preferred cooling in the furnace may cause the mineral composition of the mixture containing the tetracalcium phosphate to change, that is, the content of the tetracalcium phosphate will be reduced; therefore, the rapid cooling step can keep the freshly sintered The mineral component of the mixture containing the tetracalcium phosphate results in a product containing higher purity tetracalcium phosphate.

另外,為了配合磷酸四鈣的應用產品,會進一步將該含有該磷酸四鈣之混合物進行研磨過篩,使該含有該磷酸四鈣之混合物形成一定粒徑大小的產物,以利後續的應用。因此本發明的方法進一步包含步驟(5),其接於步驟(4)後,其包含研磨該含有該磷酸四鈣之混合物成粉體,得一磷酸四鈣粉體。於一具體實施例中,該磷酸四鈣粉體之粒徑小於150μm。於一較佳具體實施例中,該磷酸四鈣粉體之粒徑小於100μm。於一更佳具體實施例中,該磷酸四鈣粉體之粒徑小於75μm。於另一具體實施例中,該磷酸四鈣粉體之粒徑小於50μm。 In addition, in order to cooperate with the application product of tetracalcium phosphate, the mixture containing the tetracalcium phosphate is further ground and sieved, so that the mixture containing the tetracalcium phosphate is formed into a product with a certain particle size to facilitate subsequent applications. Therefore, the method of the present invention further includes step (5), which is followed by step (4), which comprises grinding the mixture containing the tetracalcium phosphate into a powder to obtain a tetracalcium phosphate powder. In a specific embodiment, the particle size of the tetracalcium phosphate powder is less than 150 μm. In a preferred embodiment, the particle size of the tetracalcium phosphate powder is less than 100 μm. In a more specific embodiment, the particle size of the tetracalcium phosphate powder is less than 75 μm. In another specific embodiment, the particle size of the tetracalcium phosphate powder is less than 50 μm.

該含有該磷酸四鈣之混合物包含該磷酸四鈣以及一氫氧基磷灰石(HAp)。於一具體實施例中,該磷酸四鈣佔該含有該磷酸四鈣之混合物之重量百分比為60%以上。於一較佳具體實施例中,該磷酸四鈣佔該含有該磷酸四鈣之混合物之重量百分比為80%以上。於一更佳具體實施例中,該磷酸四鈣佔該含有該磷酸四鈣之混合物之重量百分比為90%以上。於另一具體實施例中,該氫氧基磷灰石佔該含有該磷酸四鈣之混合物之重量百分比為40%以下。於一較佳具體實施例中,該氫氧基磷灰石佔該含有該磷酸四鈣之混合物之重量百分比為20%以下。於一更佳具體實施例中,該氫氧基磷灰石佔該含有該磷酸四鈣之混合物之重量百分比為10%以下。 The mixture containing the tetracalcium phosphate includes the tetracalcium phosphate and a monohydroxyapatite (HAp). In a specific embodiment, the weight percentage of the tetracalcium phosphate to the mixture containing the tetracalcium phosphate is more than 60%. In a preferred embodiment, the weight percentage of the tetracalcium phosphate to the mixture containing the tetracalcium phosphate is more than 80%. In a more specific embodiment, the weight percentage of the tetracalcium phosphate in the mixture containing the tetracalcium phosphate is more than 90%. In another specific embodiment, the weight percentage of the hydroxylapatite to the mixture containing the tetracalcium phosphate is 40% or less. In a preferred embodiment, the weight percentage of the hydroxylapatite to the mixture containing the tetracalcium phosphate is less than 20%. In a more specific embodiment, the weight percentage of the hydroxide apatite to the mixture containing the tetracalcium phosphate is 10% or less.

本發明的磷酸四鈣粉體可用於生物材料,例如骨水泥,可作為人造骨骼與牙齒根管封填材料使用,亦可作為合成乳酸磷酸鈣的原料;此外,若提升磷酸鈣粉體於液相解離(鈣離子與磷酸根離子)程度,則可作為人體鈣質補充劑以及牙齒保健修復材料。 The tetracalcium phosphate powder of the present invention can be used in biological materials, such as bone cement, as an artificial bone and dental root canal sealing material, and as a raw material for synthesizing calcium lactate phosphate. In addition, if the calcium phosphate powder is improved in liquid The degree of phase dissociation (calcium ions and phosphate ions) can be used as human calcium supplements and dental health repair materials.

本發明提供一種骨水泥,具有一圓球狀的結構,其中該骨水泥的材質為一磷酸鹽。 The invention provides a bone cement having a spherical structure, wherein the material of the bone cement is a phosphate.

於一具體實施例中,該磷酸鹽包含一磷酸四鈣及一氫氧基磷灰石。於一較佳具體實施例中,該磷酸四鈣之形狀為一單斜晶體。於另一具體實施例中,該氫氧基磷灰石之形狀為一六方晶體。 In a specific embodiment, the phosphate comprises tetracalcium phosphate and a hydroxide apatite. In a preferred embodiment, the shape of the tetracalcium phosphate is a monoclinic crystal. In another specific embodiment, the shape of the hydroxylapatite is a hexagonal crystal.

於一具體實施例中,該圓球狀的結構之直徑小於150μm。於一較佳具體實施例中,該圓球狀的結構之直徑小於100μm。於一更佳具體實施例中,該圓球狀的結構之直徑小於75μm。 In a specific embodiment, the diameter of the spherical structure is less than 150 μm. In a preferred embodiment, the diameter of the spherical structure is less than 100 μm. In a more specific embodiment, the diameter of the spherical structure is less than 75 μm.

於一具體實施例中,該磷酸四鈣佔該磷酸鹽之重量百分比為60%以上。於一較佳具體實施例中,該磷酸四鈣佔該磷酸鹽之重量百分比為80%以上。於一更佳具體實施例中,該磷酸四鈣佔該磷酸鹽之重量百分比為90%以上。於另一具體實施例中,該氫氧基磷灰石佔該磷酸鹽之重量百分比為40%以下。於一較佳具體實施例中,該氫氧基磷灰石佔該磷酸鹽之重量百分比為20%以下。於一更佳具體實施例中,該氫氧基磷灰石佔該磷酸鹽之重量百分比為10%以下。 In a specific embodiment, the weight percentage of the tetracalcium phosphate to the phosphate is more than 60%. In a preferred embodiment, the weight percentage of the tetracalcium phosphate to the phosphate is more than 80%. In a more specific embodiment, the weight percentage of the tetracalcium phosphate to the phosphate is more than 90%. In another embodiment, the weight percentage of the hydroxide apatite to the phosphate is 40% or less. In a preferred embodiment, the weight percentage of the hydroxide apatite to the phosphate is less than 20%. In a more specific embodiment, the weight percentage of the hydroxide apatite to the phosphate is less than 10%.

本發明所提供之製備磷酸四鈣的方法,與其他習用技術相互 比較時,更具有下列之優點:(1)一般而言,魚鱗屬於魚類之非食用部份之生物廢棄物,除非經過特別加工處理,否則魚鱗並無任何利用價值。因此,本發明的製程可從魚鱗製備出磷酸四鈣,使魚鱗有額外的應用價值;故本發明之製程可達「零廢棄」、「資源再利用」及「提升再利用產品附加價值」之功效,因此本發明甚具實用價值;以及(2)本發明的製程相較於傳統的磷酸四鈣製備方法更為簡便快速,故提高製程的效率;同時本發明之製程過程中所使用溫度也相較傳統的製程低,故本發明能有效降低熱耗能以及減少高溫造成的環境影響。而且,只要高溫燒結時生料粉體中的氧化鈣對五氧化二磷(CaO/P2O5)之配比適當,就可製備出高純度(大於90%)的磷酸四鈣,大幅提高了產能。 Compared with other conventional technologies, the method for preparing tetracalcium phosphate provided by the present invention has the following advantages: (1) Generally speaking, fish scales are biological wastes of the non-edible part of fish, unless specially processed. Treatment, otherwise the fish scales have no use value. Therefore, the process of the present invention can prepare tetracalcium phosphate from fish scales, so that the fish scales have additional application value; therefore, the process of the present invention can reach "zero waste", "recycling of resources" and "improving the added value of reused products". Efficacy, so the present invention is of practical value; and (2) the process of the present invention is simpler and faster than the traditional method of preparing tetracalcium phosphate, thus improving the efficiency of the process; at the same time, the temperature used in the process of the present invention is also Compared with the traditional manufacturing process, the present invention can effectively reduce heat consumption and reduce environmental impact caused by high temperature. In addition, as long as the ratio of calcium oxide to phosphorus pentoxide (CaO / P 2 O 5 ) in the raw meal powder is appropriate at high temperature sintering, high-purity (more than 90%) tetracalcium phosphate can be prepared, which can greatly improve Production capacity.

10‧‧‧骨水泥 10‧‧‧ bone cement

100‧‧‧圓球狀的結構 100‧‧‧ spherical structure

200‧‧‧磷酸四鈣 200‧‧‧tetracalcium phosphate

300‧‧‧氫氧基磷灰石 300‧‧‧ Hydroxyapatite

圖1為本發明之製備磷酸四鈣的流程。 FIG. 1 is a process for preparing tetracalcium phosphate according to the present invention.

圖2為魚鱗於不同熱處理後之研磨結果。圖2(A)為魚鱗未經熱處理而破碎研磨之情況。圖2(B)為魚鱗經90℃熱處理而破碎研磨之情況。圖2(C)為魚鱗經380℃熱處理而破碎研磨之情況。圖2(D)為魚鱗於不同熱處理溫度(未熱處理、90℃熱處理及380℃熱處理)後破碎研磨之過篩率(使用30號篩網)。 Figure 2 shows the grinding results of fish scales after different heat treatments. Figure 2 (A) shows the fish scales being crushed and ground without heat treatment. Figure 2 (B) shows the fish scales being crushed and ground by heat treatment at 90 ° C. Figure 2 (C) shows the fish scales being crushed and ground by heat treatment at 380 ° C. Figure 2 (D) shows the sieving rate of the fish scales after being crushed and ground (using a 30 mesh screen) after different heat treatment temperatures (unheated, 90 ° C and 380 ° C).

圖3為添加不同量之碳酸鈣於魚鱗粉體中所造成之X-射線 繞射分析(XRD)之礦物相的變化。圖3(A)為不添加碳酸鈣之XRD之礦物相的結果。圖3(B)為添加重量百分比10%之碳酸鈣之XRD之礦物相的結果。圖3(C)為添加重量百分比15%之碳酸鈣之XRD之礦物相的結果。圖3(D)為添加重量百分比20%之碳酸鈣之XRD之礦物相的結果。圖3(E)為添加重量百分比25%之碳酸鈣之XRD之礦物相的結果。三角形為磷酸四鈣(tetracalcium phosphate;TTCP)。 Figure 3 shows the X-rays caused by adding different amounts of calcium carbonate to fish scale powder. Change of mineral phase in diffraction analysis (XRD). Figure 3 (A) shows the results of the mineral phase of XRD without calcium carbonate. FIG. 3 (B) shows the result of mineral phase of XRD with 10% calcium carbonate added by weight. Fig. 3 (C) shows the result of mineral phase of XRD with 15% by weight of calcium carbonate added. Fig. 3 (D) shows the result of the mineral phase of XRD in which 20% by weight of calcium carbonate was added. FIG. 3 (E) shows the result of the mineral phase of XRD in which 25% by weight of calcium carbonate was added. The triangle is tetracalcium phosphate (TTCP).

圖4為以裏特沃爾德-X-射線繞射分析(Rietveld XRD)鑑定量化以CaO/P2O5為1.45的生料粉體燒結所得之含有磷酸四鈣之混合物中各礦物相比例試驗結果。藍線為CaO/P2O5為1.45的生料粉體燒結所得之含有磷酸四鈣之混合物之礦物晶相之XRD標準圖譜;紅線為裏特沃爾德-X-射線繞射分析法之模擬計算圖譜;以及黑線為誤差結果。藍線與紅線相互對比後,可得知含有磷酸四鈣之混合物中磷酸四鈣成分約達92%,其餘為氫氧基磷灰石(HAp),其約8%。 Figure 4 is a comparative example of various minerals in a mixture containing tetracalcium phosphate obtained by sintering a raw meal powder with CaO / P 2 O 5 of 1.45 identified by Rietveld-X-ray diffraction analysis (Rietveld XRD) test results. The blue line is the XRD standard spectrum of the mineral crystal phase of the mixture containing tetracalcium phosphate obtained from the sintering of the raw meal powder with CaO / P 2 O 5 of 1.45; the red line is the one of the Rietwald-X-ray diffraction analysis method. The calculated spectrum is simulated; and the black line is the error result. After the blue line and the red line are compared with each other, it can be known that the composition of tetracalcium phosphate in the mixture containing tetracalcium phosphate reaches about 92%, and the rest is hydroxyl apatite (HAp), which is about 8%.

圖5為本發明之骨水泥的結構。 Figure 5 shows the structure of the bone cement of the present invention.

本發明包括但不限於上述與下開之說明。實施方式則如下範例所示。 The present invention includes, but is not limited to, the above and below descriptions. The implementation is shown in the following example.

1.材料與方法 1. Materials and methods

(a)魚鱗之熱分析與熱前處理試驗 (a) Thermal analysis and thermal pretreatment test of fish scales

本發明利用一般魚鱗以作為製備磷酸四鈣(tetracalcium phosphate;TTCP)粉體的原料使用,因此為了解經熱處理魚鱗可利用研磨設備破碎成粉末狀的特性,本發明利用熱重/熱差分析儀(TG/DTA,Hitachi TG7200)探討魚鱗熱裂解特性,樣品升溫條件由25℃生溫至600℃;升溫速率為10℃/min。經熱處理之魚鱗,以破碎研磨設備進行研磨5分鐘並以30號篩網(ASTM No.30 mesh)過篩,探討經不同溫度處理之魚鱗對於破碎過篩率的影響。 The present invention uses general fish scales as a method for preparing tetracalcium phosphate. Phosphate (TTCP) powder is used as a raw material, so in order to understand the characteristics of heat-treated fish scales that can be broken into powder by grinding equipment, the present invention uses a thermogravimetric / thermal difference analyzer (TG / DTA, Hitachi TG7200) to explore the thermal cracking characteristics of fish scales. , The temperature rise condition of the sample is from 25 ° C to 600 ° C; the temperature increase rate is 10 ° C / min. The heat-treated fish scales were ground for 5 minutes with a crushing and grinding equipment and sieved with a No. 30 mesh (ASTM No. 30 mesh) to investigate the effect of fish scales treated at different temperatures on the crushing and screening rate.

(b)魚鱗之氧化鈣對五氧化二磷(CaO/P2O5)的配比控制 (b) Proportion control of calcium oxide to phosphorus pentoxide (CaO / P 2 O 5 ) in fish scales

本發明將魚鱗經水洗去除表面汙染物後,利用高溫爐以380℃進行乾燥與煅燒前處理,經熱前處理後之魚鱗,以研磨設備進行研磨成魚鱗粉體,並使用30號篩網粉過篩該粉體;而魚鱗粉體(380℃煅燒後)與碳酸鈣粉末化學成分如表1所示。本發明添加不同比例之碳酸鈣粉末(重量百分比0%、10%、15%、20%與25%)於魚鱗粉體中,以對該魚鱗粉體進行配料設計,使該魚鱗粉體於高溫燒結時,其所含的氧化鈣對五氧化二磷(CaO/P2O5)之莫耳比值分別控制為1.15、1.28、1.36、1.45、及1.55。 In the invention, after the fish scales are washed with water to remove surface contaminants, they are dried and calcined at a temperature of 380 ° C using a high-temperature furnace, and the fish scales after the thermal pretreatment are ground into a fish scale powder by a grinding device, and a No. 30 sieve powder The powder is sieved; the chemical composition of the fish scale powder (after calcination at 380 ° C) and the calcium carbonate powder is shown in Table 1. In the present invention, calcium carbonate powders (0%, 10%, 15%, 20%, and 25% by weight) of different proportions are added to the fish scale powder, so that the fish scale powder is formulated to make the fish scale powder at high temperature. During sintering, the molar ratios of calcium oxide to phosphorus pentoxide (CaO / P 2 O 5 ) are controlled to be 1.15, 1.28, 1.36, 1.45, and 1.55, respectively.

(c)高溫熱燒結試驗與XRD試驗 (c) High temperature thermal sintering test and XRD test

本發明將380℃煅燒處理之魚鱗粉與碳酸鈣粉末混合後所得之生料粉體,利用高溫爐進行高溫燒結,探討生料粉體中所含之氧化鈣對五氧化二磷(CaO/P2O5)之不同莫耳比對於磷酸四鈣礦物相生成狀況之影響。為增加生料粉體於高溫中反應速率,利用25頓壓錠設備將生料粉體進行壓錠處理,將壓錠處理之磷酸四鈣原料以1350℃溫度燒結並持溫6小時進行磷酸四鈣原料模擬燒結;同時為保有燒結後礦物相活性,高溫1350℃持溫6小時後進行急速激冷處理,即生料粉體出高溫爐後於立刻於室溫下放置冷卻。燒結後的生料粉體經急速激冷後再次研磨過篩,研磨後的粉體(粒徑小於75μm)以X-射線繞射分析儀(X-ray diffraction;XRD)(XRD model D2 phaser,Bruker)進行礦物相分析,樣品掃描角度(2θ)為10-75°;掃描速率為0.015°/s;掃描時間為0.35秒進行XRD圖譜掃描分析。 In the present invention, the raw meal powder obtained by mixing the fish scale powder calcined at 380 ° C with calcium carbonate powder is sintered at a high temperature using a high-temperature furnace, and the calcium oxide and phosphorus pentoxide (CaO / P) contained in the raw meal powder are discussed. The effect of different molar ratios of 2 O 5 ) on the formation status of tetracalcium phosphate mineral phase. In order to increase the reaction rate of the raw meal powder at high temperature, the raw meal powder was subjected to ingot treatment using a 25-ton ingot press. The ingot-treated tetracalcium phosphate raw material was sintered at 1350 ° C and held at the temperature for 6 hours to simulate the tetracalcium phosphate raw material Sintering; at the same time, in order to maintain the mineral phase activity after sintering, it is subjected to rapid chilling treatment after being held at a high temperature of 1350 ° C for 6 hours. The sintered raw meal powder is rapidly ground and sieved again after being rapidly chilled. The ground powder (particle size less than 75 μm) is X-ray diffraction (XRD) (XRD model D2 phaser, Bruker) was used for mineral phase analysis. The scanning angle (2θ) of the sample was 10-75 °; the scanning rate was 0.015 ° / s; the scanning time was 0.35 seconds for XRD pattern scanning analysis.

因此,本發明的製備磷酸四鈣流程如圖1所示,本發明的流程為:(1)熱處理及研磨:將魚鱗進行熱處理(380℃處理1小時),以破壞魚鱗的有機結構而可順利研磨成魚鱗粉體;(2)添加原料:添加原料與該魚鱗粉體混合,得一生料粉體,其目的在於調整該生料粉體於燒結過程 中所含的氧化鈣對五氧化二磷之比例,其中該原料係選自由氧化鈣、氧化鈣前驅物、五氧化二磷及五氧化二磷前驅物所組成的群組;(3)高溫燒結:利用高溫爐以1350℃高溫燒結該生料粉體,以使該生料粉體中礦物相發生變化以生成出磷酸四鈣;以及(4)快速冷卻:為保有維持剛燒結完成之該生料粉體之礦物成分,即純度較高的磷酸四鈣,須要剛燒結完成之該生料粉體快速放置於室溫環境下,以造成極大的溫差而達到快速冷卻的效果,就可維持並得到高純度的磷酸四鈣。此外,所得的高純度的磷酸四鈣可進一步依據產品需求進行研磨過篩的動作,如研磨後的磷酸四鈣形成粒徑小於75μm的磷酸四鈣粉末。 Therefore, the process for preparing tetracalcium phosphate according to the present invention is shown in Figure 1. The process of the present invention is: (1) heat treatment and grinding: heat treatment of the fish scales (treatment at 380 ° C for 1 hour), so as to destroy the organic structure of the fish scales and be smooth. Grind into fish scale powder; (2) Add raw materials: Add raw materials and mix with the fish scale powder to obtain a raw meal powder, the purpose of which is to adjust the raw meal powder in the sintering process. Ratio of calcium oxide to phosphorus pentoxide contained in the raw material is selected from the group consisting of calcium oxide, calcium oxide precursor, phosphorus pentoxide, and phosphorus pentoxide precursor; (3) high temperature sintering : Using a high-temperature furnace to sinter the raw meal powder at a high temperature of 1350 ° C to change the mineral phase in the raw meal powder to produce tetracalcium phosphate; and (4) rapid cooling: in order to maintain the freshly-sintered powder The mineral composition of the raw material powder, that is, the high-purity tetracalcium phosphate, requires the raw material powder that has just been sintered to be quickly placed at room temperature to achieve a great temperature difference and achieve rapid cooling effect. High-purity tetracalcium phosphate was obtained. In addition, the obtained high-purity tetracalcium phosphate can be further ground and sieved according to product requirements, for example, the ground tetracalcium phosphate can form a tetracalcium phosphate powder with a particle size of less than 75 μm.

2.結果 2. Results

(a)魚鱗之熱分析與前處理 (a) Thermal analysis and pretreatment of fish scales

本發明利用魚鱗以作為磷酸四鈣原料使用,故為了使魚鱗能與碳酸鈣粉末進行均勻混合,魚鱗必須經過破碎研磨處理成粉末狀。但因魚鱗為有機質膠原蛋白與無機質氫氧基磷酸石所組合而成,故魚鱗具有一定的韌性特質;因此,本發明首先利用機械研磨魚鱗,發現魚鱗經機械研磨後成片狀膠結體(如圖2(A)所示),並無法有效將魚鱗中有機質與無機質進行分離,且利用30號篩網(ASTM No.30 mesh)進行過篩分離,其過篩率僅約29%。 In the present invention, fish scales are used as a raw material of tetracalcium phosphate. Therefore, in order to enable the fish scales to be uniformly mixed with the calcium carbonate powder, the fish scales must be crushed and ground into powder. However, because the fish scale is a combination of organic collagen and inorganic hydroxide phosphate stone, the fish scale has certain toughness characteristics; therefore, the present invention first uses mechanical grinding of the fish scale, and finds that the fish scale is mechanically ground into a sheet-like cement (such as As shown in Figure 2 (A)), the organic matter and the inorganic matter in the fish scale cannot be effectively separated, and the sieving rate is only about 29% by sieving with a No. 30 mesh.

因此為了有效破壞魚鱗的有機結構,本發明利用熱重/熱差分析儀分析魚鱗的熱裂解溫度,而從魚鱗之熱重/熱差分析試驗結果顯示,於溫度分別於56℃與343℃時具有最大速率的熱重損失速率,熱重損失率 分別為13.1%與26.7%(數據未顯示),分別表示魚鱗表面水揮發與魚鱗發生結構裂解。因此,將魚鱗分別以90℃與380℃溫度進行熱處理,利用研磨機研磨5分鐘後利用30號篩網過篩分離。利用90℃熱處理後之魚鱗,經破碎研磨,仍呈現棉絮結構(如圖2(B)所示),無法完全破碎研磨成粉末態,故其破碎過篩率為35%,與未經熱處理之魚鱗破碎過篩率差異不大。然而,經380℃熱處理魚鱗,其完全破碎研磨成粉末態(如圖2(C)所示),其過篩率提升至100%,大幅提升魚鱗研磨效率。圖2(D)顯示魚鱗於不同熱處理溫度(未熱處理、90℃熱處理及380℃熱處理)後破碎研磨之過篩率(使用30號篩網),此結果說明魚鱗經380℃熱處理,可有效破壞魚鱗內部有機質結構,使魚鱗能夠高效率處理成粉末狀態。 Therefore, in order to effectively destroy the organic structure of fish scales, the present invention uses a thermogravimetric / thermal difference analyzer to analyze the thermal cracking temperature of the fish scales, and the results of the thermogravimetric / thermal difference analysis of the fish scales show that the temperatures at 56 ° C and 343 ° C, respectively Thermogravimetric loss rate with maximum rate 13.1% and 26.7% (data not shown), respectively, indicating water volatilization on the surface of the fish scale and structural cracking of the fish scale. Therefore, the fish scales were heat-treated at a temperature of 90 ° C. and 380 ° C., ground with a grinder for 5 minutes, and then sieved through a No. 30 sieve. The fish scales after heat treatment at 90 ° C are still crushed and ground, and still show a cotton wool structure (as shown in Figure 2 (B)). They cannot be completely ground and crushed to a powder state. There is not much difference in the sieving rate of broken fish scales. However, after heat treatment at 380 ° C, the fish scales were completely crushed and ground to a powder state (as shown in Figure 2 (C)), and the sieving rate was increased to 100%, which greatly improved the grinding efficiency of the fish scales. Figure 2 (D) shows the sieving rate of the fish scales after being crushed and ground (using No. 30 sieve) after different heat treatment temperatures (unheated, 90 ° C and 380 ° C heat treatment). The organic matter structure inside the fish scale enables the fish scale to be efficiently processed into a powder state.

(b)XRD礦物相分析 (b) XRD mineral phase analysis

經過380℃煅燒熱處理之魚鱗透過研磨成魚鱗粉體,先利用30號篩網(ASTM No.30 mesh)進行初篩,再利用200號篩網(ASTM No.200 mesh)篩選出粒徑更小的魚鱗粉末。分別以不同的重量百分比0%、10%、15%、20%與25%之碳酸鈣粉末添加於魚鱗粉末中,使魚鱗粉末與碳酸鈣粉末均勻混合得一生料粉體,再利用高溫爐以1350℃高溫燒結6小時後經激冷處理,可得含有磷酸四鈣(tetracalcium phosphate;TTCP)之混合物,其為白色粉末。圖3(A)至圖3(E)為不同碳酸鈣添加比例對於該生料粉體中礦物相生長的影響,該試驗結果顯示,當碳酸鈣添加比例為0%時,CaO/P2O5比為1.15時,主要結構仍為魚鱗既有的氫氧基磷灰石(hydroxyapatite;HAp)結構,然而,隨著碳酸鈣添加比例增加時,XRD 圖譜結構出現磷酸四鈣結構,說明氧化鈣(CaO)與魚鱗的氫氧基磷灰石(HAp)發生鍵結反應,逐漸生長出磷酸四鈣結構。然而,當碳酸鈣添加比例增加至25%,CaO/P2O5比為1.55,多餘的氧化鈣無法與氫氧基磷灰石(HAp)發生燒結反應,使得磷酸四鈣粉體存在多於的游離石灰(free-CaO;f-CaO),可能造成磷酸四鈣(tetracalcium phosphate;TTCP)應用時會有體積穩定性的影響。因此,由圖3之圖譜中顯示,較佳的碳酸鈣添加比例為20%,即當生料粉體之成分組成中CaO/P2O5為1.45時,具有較適當的磷酸四鈣(TTCP)生成。 Fish scales which have been calcined and heat-treated at 380 ° C are ground into fish scale powder. Firstly, they are sieved with a No. 30 mesh (ASTM No. 30 mesh), and then they are sieved with a smaller size (ASTM No. 200 mesh). Fish scale powder. Add different weight percentages of 0%, 10%, 15%, 20%, and 25% calcium carbonate powder to the fish scale powder, so that the fish scale powder and calcium carbonate powder are evenly mixed to obtain a raw meal powder. After being sintered at 1350 ° C for 6 hours, the mixture is quenched to obtain a mixture containing tetracalcium phosphate (TTCP), which is a white powder. Figures 3 (A) to 3 (E) are the effects of different calcium carbonate addition ratios on the mineral phase growth in the raw meal powder. The test results show that when the calcium carbonate addition ratio is 0%, CaO / P 2 O When the ratio of 5 is 1.15, the main structure is still the existing hydroxyapatite (HAp) structure of the fish scale. However, as the proportion of calcium carbonate is increased, the structure of XRD spectrum shows a tetracalcium phosphate structure, indicating that calcium oxide (CaO) reacts with fish scale's hydroxide apatite (HAp), and a tetracalcium phosphate structure gradually grows. However, when the calcium carbonate addition ratio was increased to 25% and the CaO / P 2 O 5 ratio was 1.55, the excess calcium oxide could not undergo a sintering reaction with the hydroxyapatite (HAp), so that more than four calcium phosphate powders existed. Free lime (free-CaO; f-CaO) may cause the volume stability of tetracalcium phosphate (TTCP). Therefore, as shown in the map of FIG. 3, the preferred calcium carbonate addition ratio is 20%, that is, when the CaO / P 2 O 5 content of the raw material powder composition is 1.45, it has a more appropriate tetracalcium phosphate (TTCP )generate.

為了解磷酸四鈣生成比例,本發明利用裏特沃爾德-X-射線繞射分析(Rietveld XRD)鑑定量化所燒結出的含有磷酸四鈣之混合物中磷酸四鈣的比例。而裏特沃爾德-X-射線繞射分析法要進行模擬計算時,要與一設定標準圖譜作為基準值;故以CaO/P2O5為1.45的生料粉體燒結所得之含有磷酸四鈣之混合物重新經過設定檢測條件以得一礦物晶相之標準圖譜(如圖4中藍線部分),再與裏特沃爾德-X-射線繞射分析法之模擬計算圖譜(如圖4中紅線部分)相互比對。圖4為以Rietveld XRD鑑定量化以CaO/P2O5為1.45的生料粉體燒結所得之含有磷酸四鈣之混合物中各礦物相比例試驗結果。該試驗結果顯示,磷酸四鈣生成率約為92%,其餘為氫氧基磷灰石(HAp)結構,其約8%。該結果說明利用魚鱗製備磷酸四鈣粉體,透過一定燒結溫度處理後可得到90%以上之高純度之磷酸四鈣,與傳統磷酸四鈣化學製備方法具有顯著差異。 In order to understand the formation ratio of tetracalcium phosphate, the present invention uses Rietveld-X-ray diffraction analysis (Rietveld XRD) to identify and quantify the proportion of tetracalcium phosphate in the sintered mixture containing tetracalcium phosphate. The Rietwald-X-ray diffraction analysis method needs to set a standard spectrum as a reference value when performing simulation calculations. Therefore, the sintered raw meal powder with CaO / P 2 O 5 of 1.45 contains tetraphosphoric acid. The calcium mixture passes through the set detection conditions again to obtain a standard spectrum of the mineral crystal phase (as shown by the blue line in Figure 4), and then calculates the spectrum with the simulation of Rietwald-X-ray diffraction analysis (see Figure 4). The middle red line) compares with each other. FIG. 4 shows the results of a comparative example of various minerals in a mixture containing tetracalcium phosphate obtained by sintering a raw meal powder having CaO / P 2 O 5 of 1.45 as quantified by Rietveld XRD. The test results show that the formation rate of tetracalcium phosphate is about 92%, and the rest is a hydroxide apatite (HAp) structure, which is about 8%. The results show that the use of fish scales to prepare tetracalcium phosphate powder can obtain more than 90% high-purity tetracalcium phosphate after a certain sintering temperature treatment, which is significantly different from the traditional chemical preparation method of tetracalcium phosphate.

此外,表2為醫療級磷酸四鈣粉體之重金屬成分規格表,其 中鉛(Pb)、汞(Hg)、砷(As)、鎘(Cd)含量需分別小於30、5、3、5ppm。本發明利用CaO/P2O5為1.45的魚鱗粉與碳酸鈣混合原料,經燒結後得之磷酸四鈣粉體,其以X-射線螢光分析(X-Ray Fluorescence;XRF)進行化學成分分析,該化學成分之分析結果如表3所示,本發明之磷酸四鈣(TTCP)粉末之化學主成分為鈣與磷元素,且重金屬含量小,僅存在少量的鉻(Cr)、錳(Mn)等重金屬元素,符合醫療級磷酸四鈣粉體的規格。 In addition, Table 2 is a heavy metal composition specification table for medical grade tetracalcium phosphate powder, in which the content of lead (Pb), mercury (Hg), arsenic (As), and cadmium (Cd) needs to be less than 30, 5, 3, and 5 ppm, respectively. The present invention uses a mixed raw material of fish scale powder and calcium carbonate with CaO / P 2 O 5 of 1.45 to obtain tetracalcium phosphate powder after sintering. The chemical composition is analyzed by X-Ray Fluorescence (XRF). According to analysis, the analysis result of the chemical composition is shown in Table 3. The chemical main components of the tetracalcium phosphate (TTCP) powder of the present invention are calcium and phosphorus elements, and the content of heavy metals is small, and only a small amount of chromium (Cr), manganese ( Mn) and other heavy metal elements, which meet the specifications of medical grade tetracalcium phosphate powder.

ND:無法偵測 ND: Undetectable

因此利用本發明所製作出的磷酸四鈣作成骨填補材料,即骨水泥。圖5為本發明之骨水泥的結構10,具有一圓球狀的結構100,且其材質為一磷酸鹽。而該磷酸鹽包含一磷酸四鈣200及一氫氧基磷灰石300,其中該磷酸四鈣200之形狀為一單斜晶體,而該氫氧基磷灰石300之形狀為一六方晶體。 Therefore, the tetracalcium phosphate produced by the present invention is used as a bone filling material, that is, bone cement. FIG. 5 is a structure 10 of the bone cement of the present invention, which has a spherical structure 100, and the material thereof is a phosphate. The phosphate contains tetracalcium phosphate 200 and a hydroxide apatite 300. The shape of the tetracalcium phosphate 200 is a monoclinic crystal, and the shape of the hydroxide apatite 300 is a hexagonal crystal. .

本發明適當的描述可以在本文未具體公開的元素或限制下實施。已被用作描述的術語並不是限制。在使用這些術語和除此之外的任何等同物的表達和描述是沒有差別的,但應當認識到本發明內的權利是可能修改的。因此,雖然本發明已說明實施例和其他情況,本文中所公開的內容可以被本領域的技術人員進行修飾和變化,並且這樣的修改和變化被認為是在本發明的權利範圍之內。 Appropriate descriptions of the invention may be implemented with elements or limitations not specifically disclosed herein. Terms that have been used for description are not restrictive. There is no difference in the expression and description of these terms and any equivalents other than this, but it should be recognized that the rights within the present invention are possible to modify. Therefore, although the present invention has described embodiments and other circumstances, the contents disclosed herein can be modified and changed by those skilled in the art, and such modifications and changes are considered to be within the scope of the rights of the present invention.

Claims (10)

一種製備磷酸四鈣的方法,其包含:(1)熱處理一魚鱗,並將該魚鱗研磨成粉體,得一魚鱗粉體;(2)添加一原料於該魚鱗粉體中,得一生料粉體,其中該原料係選自一氧化鈣、一氧化鈣前驅物、一五氧化二磷及一五氧化二磷前驅物所組成的群組;以及(3)高溫燒結該生料粉體,使該生料粉體中的氧化鈣對五氧化二磷(CaO/P2O5)之莫耳比值的範圍為1.2至1.7,且高溫燒結完成後得一含有一磷酸四鈣之混合物。A method for preparing tetracalcium phosphate, comprising: (1) heat-treating a fish scale and grinding the fish scale into a powder to obtain a fish scale powder; (2) adding a raw material to the fish scale powder to obtain a raw meal powder The raw material is selected from the group consisting of calcium monoxide, calcium monoxide precursor, phosphorus pentoxide and phosphorus pentoxide precursor; and (3) sintering the raw meal powder at high temperature, so that The molar ratio of calcium oxide to phosphorus pentoxide (CaO / P 2 O 5 ) in the raw meal powder ranges from 1.2 to 1.7, and a mixture containing tetracalcium phosphate monophosphate is obtained after high temperature sintering is completed. 如申請專利範圍第1項所述之方法,其中該熱處理之溫度大於300℃。The method according to item 1 of the scope of patent application, wherein the temperature of the heat treatment is greater than 300 ° C. 如申請專利範圍第1項所述之方法,其中該魚鱗粉體之粒徑範圍為20μm至800μm。The method according to item 1 of the patent application range, wherein the particle size of the fish scale powder ranges from 20 μm to 800 μm. 如申請專利範圍第1項所述之方法,其中該氧化鈣前驅物包含一碳酸鈣、一葡萄酸鈣及一檸檬酸鈣。The method of claim 1, wherein the calcium oxide precursor comprises calcium carbonate, calcium gluconate, and calcium citrate. 如申請專利範圍第1項所述之方法,其中該五氧化二磷前驅物包含一磷灰石、一氫氧基磷灰石、一二水磷酸氫鈣及一魚鱗。The method according to item 1 of the scope of the patent application, wherein the phosphorus pentoxide precursor comprises apatite, monohydroxyapatite, calcium hydrogen phosphate dihydrate, and a fish scale. 如申請專利範圍第1項所述之方法,其中該高溫燒結之溫度大於1000℃。The method according to item 1 of the scope of patent application, wherein the temperature of the high-temperature sintering is greater than 1000 ° C. 如申請專利範圍第1項所述之方法,其進一步包含一步驟(4),其接於步驟(3)後,其包含冷卻該含有該磷酸四鈣之混合物。The method according to item 1 of the scope of patent application, further comprising a step (4), which is subsequent to the step (3) and comprises cooling the mixture containing the tetracalcium phosphate. 如申請專利範圍第7項所述之方法,其中該冷卻該含有該磷酸四鈣之混合物係將該含有該磷酸四鈣之混合物於室溫冷卻。The method according to item 7 of the scope of patent application, wherein the cooling the mixture containing the tetracalcium phosphate is cooling the mixture containing the tetracalcium phosphate at room temperature. 如申請專利範圍第7項所述之方法,其進一步包含步驟(5),其接於步驟(4)後,其包含研磨該含有該磷酸四鈣之混合物成粉體,得一磷酸四鈣粉體。The method according to item 7 of the patent application scope, further comprising step (5), which is followed by step (4), which comprises grinding the mixture containing the tetracalcium phosphate into a powder to obtain a tetracalcium phosphate powder body. 如申請專利範圍第9項所述之方法,其中該磷酸四鈣粉體之粒徑小於150μm。The method according to item 9 of the scope of patent application, wherein the particle diameter of the tetracalcium phosphate powder is less than 150 μm.
TW106103267A 2017-01-26 2017-01-26 Method for preparing tetracalcium phosphate TWI623492B (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TW106103267A TWI623492B (en) 2017-01-26 2017-01-26 Method for preparing tetracalcium phosphate
CN201710242621.4A CN108358183A (en) 2017-01-26 2017-04-14 Process for preparing tetracalcium phosphate
JP2017088312A JP6318282B1 (en) 2017-01-26 2017-04-27 Method for preparing tetracalcium phosphate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW106103267A TWI623492B (en) 2017-01-26 2017-01-26 Method for preparing tetracalcium phosphate

Publications (2)

Publication Number Publication Date
TWI623492B true TWI623492B (en) 2018-05-11
TW201827339A TW201827339A (en) 2018-08-01

Family

ID=62069469

Family Applications (1)

Application Number Title Priority Date Filing Date
TW106103267A TWI623492B (en) 2017-01-26 2017-01-26 Method for preparing tetracalcium phosphate

Country Status (3)

Country Link
JP (1) JP6318282B1 (en)
CN (1) CN108358183A (en)
TW (1) TWI623492B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7373330B2 (en) 2018-09-25 2023-11-02 Dowaエコシステム株式会社 Method for manufacturing hydroxyapatite
CN111718589B (en) * 2020-07-16 2021-10-26 长沙理工大学 Asphalt modification method using fish scales as modifier and modified asphalt
CN112607719B (en) * 2020-12-02 2022-04-15 中山职业技术学院 High-mechanical-property tetracalcium phosphate nano powder for 3D printing and preparation method thereof
CN112479173B (en) * 2020-12-02 2022-06-17 中山职业技术学院 Tetracalcium phosphate nano powder for 3D printing and capable of enabling printed bone finished products to have high pore connectivity and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101880033A (en) * 2010-03-04 2010-11-10 上海纳米技术及应用国家工程研究中心有限公司 Method for preparing calcium phosphate for biological ceramics
CN101946907A (en) * 2010-08-06 2011-01-19 海南大学 Method for producing collagen calcium

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0196006A (en) * 1987-10-08 1989-04-14 Kotegawa Sangyo Kk Production of tetracalcium phosphate
JPH04265214A (en) * 1991-02-18 1992-09-21 Kanebo Ltd Production of hydroxyapatite
JP3668530B2 (en) * 1995-07-27 2005-07-06 太平化学産業株式会社 Method for producing tetracalcium phosphate
EP1092679A4 (en) * 1999-03-26 2005-03-09 Nara Machinery Co Ltd Method for producing calcium phosphate powder
CN1727304A (en) * 2004-07-30 2006-02-01 段维新 Hydroxyapatite powder, porous body, and preparation method
CN101264871A (en) * 2008-03-27 2008-09-17 上海交通大学 Method for preparing tetracalcium phosphate from natural bone powder

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101880033A (en) * 2010-03-04 2010-11-10 上海纳米技术及应用国家工程研究中心有限公司 Method for preparing calcium phosphate for biological ceramics
CN101946907A (en) * 2010-08-06 2011-01-19 海南大学 Method for producing collagen calcium

Also Published As

Publication number Publication date
TW201827339A (en) 2018-08-01
CN108358183A (en) 2018-08-03
JP2018118896A (en) 2018-08-02
JP6318282B1 (en) 2018-04-25

Similar Documents

Publication Publication Date Title
TWI623492B (en) Method for preparing tetracalcium phosphate
Mondal et al. Physico-chemical characterization and biological response of Labeo rohita-derived hydroxyapatite scaffold
Alif et al. A hydrothermal synthesis of natural hydroxyapatite obtained from Corbicula moltkiana freshwater clams shell biowaste
CA2438742C (en) A new calcium phosphate cement composition and a method for the preparation thereof
CN107141022B (en) Whitlockite coating constructed on surface of calcium phosphate biological ceramic matrix and preparation method thereof
Bee et al. Effect of the calcination temperature on the properties of natural hydroxyapatite derived from chicken bone wastes
Zanelato et al. Development of biphasic bone cement obtained from chicken eggshell
Noviyanti et al. The effect of Mg concentration to mechanical strength of hydroxyapatite derived from eggshell
Vecbiskena et al. Crystallized nano-sized alpha-tricalcium phosphate from amorphous calcium phosphate: microstructure, cementation and cell response
Carbajal et al. Design and processing of ZnO doped tricalcium phosphate based materials: Influence of β/α polymorph phase assemblage on microstructural evolution
Ghedjemis et al. Preparation of hydroxyapatite from dromedary bone by heat treatment
Zia et al. Titania doped bioactive ceramics prepared by solid state sintering method
Mustaffa et al. A novelty of synthetic hydroxyapatite from cockle shell and characterization
WO2011121087A1 (en) A glass ceramic biomaterial
KR101907408B1 (en) Manufacturing Method Of Calcium Phosphate Using Eggshell And Phosphate-ammonia solution
Noor Green synthesis of calcium magnesium silicate (CMS-Akermanite) using natural biowastes by solid-state sintering route
CN107746268B (en) Anorthite/calcium silicate composite biological ceramic material and preparation method thereof
Dong et al. Effects of calcination temperature of boron-containing magnesium oxide raw materials on properties of magnesium phosphate cement as a biomaterial
Naga et al. Physicomechanical, phase composition, and in vitro study of high-temperature sintered ZTA/HA composites
Pan et al. Optimization of the preparation process of α-tricalcium phosphate applied to bone cement
JPS6212705A (en) Medical and dental cement composition
Malau et al. Hydroxyapatite Preparation from Crab Shell Waste by Precipitation Method
Bouregba et al. Silicocarnotite synthesis and bioactivity in artificial saliva medium
Lee et al. Fabrication of biphasic calcium phosphate bioceramics from the recycling of bone ash
Ito et al. Preparation of spherical granules of octacalcium phosphate for medical application